{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T15:10:28Z","timestamp":1790694628306,"version":"4.1.0"},"reference-count":52,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2024,10,23]],"date-time":"2024-10-23T00:00:00Z","timestamp":1729641600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P30 AG072946"],"award-info":[{"award-number":["P30 AG072946"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 AG061111"],"award-info":[{"award-number":["R01 AG061111"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["RF1 NS118584"],"award-info":[{"award-number":["RF1 NS118584"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 AG057187"],"award-info":[{"award-number":["R01 AG057187"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,1,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>This review discusses terminology recently proposed for the classification of dementia and, more specifically, nosology related to aging-associated TDP-43 pathology: limbic-predominant age-related TDP-43 encephalopathy (LATE), and limbic-predominant amnestic neurodegenerative syndrome (LANS). While the \u201cgold standard\u201d for these clinical conditions is still LATE neuropathologic changes (LATE-NC), clinical criteria and biomarkers are evolving. The newly proposed clinical rubrics are discussed with emphasis on the need for terminology that acknowledges the distinctions between clinical syndrome-, molecular biomarker-, and pathologically defined disease concepts. As further progress is made on research into the specific biomarker-based detection and prediction of TDP-43 proteinopathy in the clinical setting, the definitions of \u201cProbable\u201d and \u201cPossible\u201d LATE are likely to become more useful clinically. For people interested in the pathological diagnoses or basic research related to LATE-NC, the relevant terminology remains unchanged by the newly proposed clinical criteria.<\/jats:p>","DOI":"10.1093\/jnen\/nlae113","type":"journal-article","created":{"date-parts":[[2024,10,23]],"date-time":"2024-10-23T16:13:24Z","timestamp":1729700004000},"page":"2-7","source":"Crossref","is-referenced-by-count":10,"title":["New criteria to predict LATE-NC in the clinical setting: Probable\/Possible LATE and LANS"],"prefix":"10.1093","volume":"84","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6161-1265","authenticated-orcid":false,"given":"Peter T","family":"Nelson","sequence":"first","affiliation":[{"name":"Sanders-Brown Center on Aging, Division of Neuropathology, Department of Pathology, University of Kentucky , Lexington, KY 40536,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,10,23]]},"reference":[{"key":"2024122007513000900_nlae113-B1","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1001\/jamaneurol.2023.3664","article-title":"A new framework for dementia nomenclature","volume":"80","author":"Petersen","year":"2023","journal-title":"JAMA Neurol"},{"key":"2024122007513000900_nlae113-B2","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1212\/WNL.0000000000007583","article-title":"A brief history of \u201cAlzheimer disease\u201d: multiple meanings separated by a common name","volume":"92","author":"Knopman","year":"2019","journal-title":"Neurology"},{"key":"2024122007513000900_nlae113-B3","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.jalz.2018.03.002","article-title":"The National Institute on Aging and the Alzheimer\u2019s Association Research Framework for Alzheimer\u2019s disease: perspectives from the Research Roundtable","volume":"14","author":"Knopman","year":"2018","journal-title":"Alzheimers Dement"},{"key":"2024122007513000900_nlae113-B4","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1038\/s41582-024-00977-5","article-title":"Acceptable performance of blood biomarker tests of amyloid pathology\u2014recommendations from the Global CEO Initiative on Alzheimer\u2019s Disease","volume":"20","author":"Schindler","year":"2024","journal-title":"Nat Rev Neurol"},{"key":"2024122007513000900_nlae113-B5","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/S1053-8119(02)00026-5","article-title":"Early diagnosis of Alzheimer\u2019s disease: contribution of structural neuroimaging","volume":"18","author":"Chetelat","year":"2003","journal-title":"Neuroimage"},{"key":"2024122007513000900_nlae113-B6","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0197-4580(98)00006-2","article-title":"MRI of the hippocampus in Alzheimer\u2019s disease: sensitivity, specificity, and analysis of the incorrectly classified subjects","volume":"19","author":"Laakso","year":"1998","journal-title":"Neurobiol Aging"},{"key":"2024122007513000900_nlae113-B7","doi-asserted-by":"crossref","first-page":"483972","DOI":"10.4061\/2011\/483972","article-title":"MRI shows more severe hippocampal atrophy and shape deformation in hippocampal sclerosis than in Alzheimer\u2019s disease","volume":"2011","author":"Zarow","year":"2011","journal-title":"Int J Alzheimers Dis"},{"key":"2024122007513000900_nlae113-B8","doi-asserted-by":"crossref","first-page":"e26286","DOI":"10.1371\/journal.pone.0026286","article-title":"Neuropathologic correlates of hippocampal atrophy in the elderly: a clinical, pathologic, postmortem MRI study","volume":"6","author":"Dawe","year":"2011","journal-title":"PLoS One"},{"key":"2024122007513000900_nlae113-B9","doi-asserted-by":"crossref","first-page":"100092","DOI":"10.1016\/j.nbas.2023.100092","article-title":"Longitudinal hippocampal atrophy in hippocampal sclerosis of aging","volume":"4","author":"Li","year":"2023","journal-title":"Aging Brain"},{"key":"2024122007513000900_nlae113-B10","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/s00401-013-1154-1","article-title":"Hippocampal sclerosis of aging, a prevalent and high-morbidity brain disease","volume":"126","author":"Nelson","year":"2013","journal-title":"Acta Neuropathol"},{"key":"2024122007513000900_nlae113-B11","doi-asserted-by":"crossref","first-page":"e754","DOI":"10.1212\/WNL.0000000000207497","article-title":"Synergistic effects of cerebrovascular and Lewy body pathology on parkinsonism","volume":"101","author":"Agrawal","year":"2023","journal-title":"Neurology"},{"key":"2024122007513000900_nlae113-B12","doi-asserted-by":"crossref","first-page":"536","DOI":"10.3390\/jcm13020536","article-title":"Controversial past, splendid present, unpredictable future: a brief review of Alzheimer disease history","volume":"13","author":"Bermejo-Pareja","year":"2024","journal-title":"J Clin Med"},{"key":"2024122007513000900_nlae113-B13","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1001\/jamaneurol.2020.1741","article-title":"Prevalence and clinical phenotype of quadruple misfolded proteins in older adults","volume":"77","author":"Karanth","year":"2020","journal-title":"JAMA Neurol"},{"key":"2024122007513000900_nlae113-B14","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1212\/01.wnl.0000271090.28148.24","article-title":"Mixed brain pathologies account for most dementia cases in community-dwelling older persons","volume":"69","author":"Schneider","year":"2007","journal-title":"Neurology"},{"key":"2024122007513000900_nlae113-B15","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/s13195-014-0082-1","article-title":"Prevalence of mixed pathologies in the aging brain","volume":"6","author":"Rahimi","year":"2014","journal-title":"Alzheimers Res Ther"},{"key":"2024122007513000900_nlae113-B16","doi-asserted-by":"crossref","first-page":"2844","DOI":"10.1093\/brain\/awaa219","article-title":"Limbic-predominant age-related TDP-43 encephalopathy differs from frontotemporal lobar degeneration","volume":"143","author":"Robinson","year":"2020","journal-title":"Brain"},{"key":"2024122007513000900_nlae113-B17","doi-asserted-by":"crossref","first-page":"2975","DOI":"10.1093\/brain\/awad145","article-title":"Data-driven neuropathological staging and subtyping of TDP-43 proteinopathies","volume":"146","author":"Young","year":"2023","journal-title":"Brain"},{"key":"2024122007513000900_nlae113-B18","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1093\/brain\/awz099","article-title":"Limbic-predominant age-related TDP-43 encephalopathy (LATE): consensus working group report","volume":"142","author":"Nelson","year":"2019","journal-title":"Brain"},{"key":"2024122007513000900_nlae113-B19","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1007\/s00401-016-1537-1","article-title":"Updated TDP-43 in Alzheimer\u2019s disease staging scheme","volume":"131","author":"Josephs","year":"2016","journal-title":"Acta Neuropathol"},{"key":"2024122007513000900_nlae113-B20","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s40478-018-0531-3","article-title":"TDP-43 pathology in anterior temporal pole cortex in aging and Alzheimer\u2019s disease","volume":"6","author":"Nag","year":"2018","journal-title":"Acta Neuropathol Commun"},{"key":"2024122007513000900_nlae113-B21","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s00401-022-02524-2","article-title":"LATE-NC staging in routine neuropathologic diagnosis: an update","volume":"145","author":"Nelson","year":"2023","journal-title":"Acta Neuropathol"},{"key":"2024122007513000900_nlae113-B22","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1093\/jnen\/nlae032","article-title":"Limbic-predominant age-related TDP-43 encephalopathy (LATE-NC): co-pathologies and genetic risk factors provide clues about pathogenesis","volume":"83","author":"Nelson","year":"2024","journal-title":"J Neuropathol Exp Neurol"},{"key":"2024122007513000900_nlae113-B23","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1002\/ana.21154","article-title":"TDP-43 immunoreactivity in hippocampal sclerosis and Alzheimer\u2019s disease","volume":"61","author":"Amador-Ortiz","year":"2007","journal-title":"Ann Neurol"},{"key":"2024122007513000900_nlae113-B24","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1186\/s40478-021-01250-2","article-title":"Analysis of genes (TMEM106B, GRN, ABCC9, KCNMB2, and APOE) implicated in risk for LATE-NC and hippocampal sclerosis provides pathogenetic insights: a retrospective genetic association study","volume":"9","author":"Dugan","year":"2021","journal-title":"Acta Neuropathol Commun"},{"key":"2024122007513000900_nlae113-B25","doi-asserted-by":"crossref","first-page":"e48","DOI":"10.1093\/brain\/awz226","article-title":"Reply: LATE to the PART-y","volume":"142","author":"Nelson","year":"2019","journal-title":"Brain"},{"key":"2024122007513000900_nlae113-B26","doi-asserted-by":"crossref","first-page":"e47","DOI":"10.1093\/brain\/awz224","article-title":"LATE to the PART-y","volume":"142","author":"Josephs","year":"2019","journal-title":"Brain"},{"key":"2024122007513000900_nlae113-B27","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s00401-022-02444-1","article-title":"Frequency of LATE neuropathologic change across the spectrum of Alzheimer\u2019s disease neuropathology: combined data from 13 community-based or population-based autopsy cohorts","volume":"144","author":"Nelson","year":"2022","journal-title":"Acta Neuropathol"},{"key":"2024122007513000900_nlae113-B28","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1002\/ana.26711","article-title":"When Alzheimer\u2019s is LATE: why does it matter?","volume":"94","author":"Nelson","year":"2023","journal-title":"Ann Neurol"},{"key":"2024122007513000900_nlae113-B29","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1038\/s41582-023-00846-7","article-title":"Limbic-predominant age-related TDP43 encephalopathy (LATE) neuropathological change in neurodegenerative diseases","volume":"19","author":"Nag","year":"2023","journal-title":"Nat Rev Neurol"},{"key":"2024122007513000900_nlae113-B30","doi-asserted-by":"crossref","first-page":"e203","DOI":"10.1212\/WNL.0000000000201345","article-title":"Impact and risk factors of limbic predominant age-related TDP-43 encephalopathy neuropathologic change in an oldest-old cohort","volume":"100","author":"Sajjadi","year":"2023","journal-title":"Neurology"},{"key":"2024122007513000900_nlae113-B31","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awae212","article-title":"Limbic-predominant age-related TDP-43 encephalopathy in the oldest old: a population-based study","author":"Mikhailenko","year":"2024","journal-title":"Brain"},{"key":"2024122007513000900_nlae113-B32","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1126\/science.1134108","article-title":"Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis","volume":"314","author":"Neumann","year":"2006","journal-title":"Science"},{"key":"2024122007513000900_nlae113-B33","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1212\/WNL.0000000000002638","article-title":"Prevalence, characteristics, and survival of frontotemporal lobar degeneration syndromes","volume":"86","author":"Coyle-Gilchrist","year":"2016","journal-title":"Neurology"},{"key":"2024122007513000900_nlae113-B34","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1007\/s12031-011-9538-y","article-title":"Estimating the number of persons with frontotemporal lobar degeneration in the US population","volume":"45","author":"Knopman","year":"2011","journal-title":"J Mol Neurosci"},{"key":"2024122007513000900_nlae113-B35","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.15585\/mmwr.mm6746a1","article-title":"Prevalence of amyotrophic lateral sclerosis\u2014United States, 2015","volume":"67","author":"Mehta","year":"2018","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2024122007513000900_nlae113-B36","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1136\/jnnp.2006.104828","article-title":"Descriptive epidemiology of amyotrophic lateral sclerosis: new evidence and unsolved issues","volume":"79","author":"Logroscino","year":"2008","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2024122007513000900_nlae113-B37","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1038\/s41374-019-0196-y","article-title":"Tau and TDP-43 proteinopathies: kindred pathologic cascades and genetic pleiotropy","volume":"99","author":"Chornenkyy","year":"2019","journal-title":"Lab Invest"},{"key":"2024122007513000900_nlae113-B38","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1136\/jnnp-2020-322983","article-title":"TDP-43 proteinopathies: a new wave of neurodegenerative diseases","volume":"92","author":"de Boer","year":"2020","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2024122007513000900_nlae113-B39","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1002\/cm.21812","article-title":"Tau and neurodegeneration","volume":"81","author":"Goedert","year":"2024","journal-title":"Cytoskeleton (Hoboken)"},{"key":"2024122007513000900_nlae113-B40","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00401-011-0910-3","article-title":"National Institute on Aging-Alzheimer\u2019s Association guidelines for the neuropathologic assessment of Alzheimer\u2019s disease: a practical approach","volume":"123","author":"Montine","year":"2012","journal-title":"Acta Neuropathol"},{"key":"2024122007513000900_nlae113-B41","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1007\/s11910-022-01232-4","article-title":"Limbic-predominant age-related TDP-43 encephalopathy: LATE-breaking updates in clinicopathologic features and biomarkers","volume":"22","author":"Duong","year":"2022","journal-title":"Curr Neurol Neurosci Rep"},{"key":"2024122007513000900_nlae113-B42","article-title":"Clinical criteria for limbic-predominant age-related TDP-43 encephalopathy","author":"Wolk","year":"2024","journal-title":"Alzheimers Dement"},{"key":"2024122007513000900_nlae113-B43","doi-asserted-by":"crossref","first-page":"fcae183","DOI":"10.1093\/braincomms\/fcae183","article-title":"A limbic-predominant amnestic neurodegenerative syndrome associated with TDP-43 pathology","volume":"6","author":"Corriveau-Lecavalier","year":"2024","journal-title":"Brain Commun"},{"key":"2024122007513000900_nlae113-B44","doi-asserted-by":"crossref","first-page":"e23","DOI":"10.1212\/WNL.0000000000009722","article-title":"Utility of FDG-PET in diagnosis of Alzheimer-related TDP-43 proteinopathy","volume":"95","author":"Buciuc","year":"2020","journal-title":"Neurology"},{"key":"2024122007513000900_nlae113-B45","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1093\/brain\/awy049","article-title":"FDG-PET in tau-negative amnestic dementia resembles that of autopsy-proven hippocampal sclerosis","volume":"141","author":"Botha","year":"2018","journal-title":"Brain"},{"key":"2024122007513000900_nlae113-B46","doi-asserted-by":"crossref","first-page":"4105","DOI":"10.1007\/s00415-024-12312-5","article-title":"A multimodal clinical diagnostic approach using MRI and (18)F-FDG-PET for antemortem diagnosis of TDP-43 in cases with low-intermediate Alzheimer\u2019s disease neuropathologic changes and primary age-related tauopathy","volume":"271","author":"Lavrova","year":"2024","journal-title":"J Neurol"},{"key":"2024122007513000900_nlae113-B47","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/2051-5960-1-65","article-title":"Clinical and multimodal biomarker correlates of ADNI neuropathological findings","volume":"1","author":"Toledo","year":"2013","journal-title":"Acta Neuropathol Commun"},{"key":"2024122007513000900_nlae113-B48","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1002\/alz.12763","article-title":"Differential diagnosis of amnestic dementia patients based on an FDG-PET signature of autopsy-confirmed LATE-NC","volume":"19","author":"Grothe","year":"2023","journal-title":"Alzheimers Dement"},{"key":"2024122007513000900_nlae113-B49","doi-asserted-by":"crossref","first-page":"4055","DOI":"10.1093\/brain\/awad133","article-title":"C-terminal TMEM106B fragments in human brain correlate with disease-associated TMEM106B haplotypes","volume":"146","author":"Vicente","year":"2023","journal-title":"Brain"},{"key":"2024122007513000900_nlae113-B50","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s00401-023-02580-2","article-title":"Limbic-predominant age-related TDP-43 proteinopathy (LATE-NC) is associated with abundant TMEM106B pathology","volume":"146","author":"Neumann","year":"2023","journal-title":"Acta Neuropathol"},{"key":"2024122007513000900_nlae113-B51","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/s00401-022-02531-3","article-title":"Accumulation of TMEM106B C-terminal fragments in neurodegenerative disease and aging","volume":"145","author":"Perneel","year":"2023","journal-title":"Acta Neuropathol"},{"key":"2024122007513000900_nlae113-B52","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1186\/s13195-024-01532-6","article-title":"Cancer research provides a model for advancing clinical trials in dementia in the era of disease-modifying Alzheimer\u2019s-type dementia therapies","volume":"16","author":"Jicha","year":"2024","journal-title":"Alzheimers Res Ther"}],"container-title":["Journal of Neuropathology &amp; Experimental Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jnen\/article-pdf\/84\/1\/2\/60009832\/nlae113.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jnen\/article-pdf\/84\/1\/2\/60009832\/nlae113.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,20]],"date-time":"2024-12-20T07:51:58Z","timestamp":1734681118000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jnen\/article\/84\/1\/2\/7833317"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,23]]},"references-count":52,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,10,23]]},"published-print":{"date-parts":[[2025,1,1]]}},"URL":"https:\/\/doi.org\/10.1093\/jnen\/nlae113","relation":{},"ISSN":["0022-3069","1554-6578"],"issn-type":[{"value":"0022-3069","type":"print"},{"value":"1554-6578","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,1]]},"published":{"date-parts":[[2024,10,23]]}}}